WRF
MCRB icon

Waddell & Reed Financial’s Seres Therapeutics MCRB Stock Holding History

Waddell & Reed Financial’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-17,705
Closed -$4.35M – 604
2016
Q3 		$4.35M Sell
17,705
-19,031
-52% -$6.68M 0.01% 528
2016
Q2 		$21.3M Buy
36,736
+7,458
+25% +$4.38M 0.05% 298
2016
Q1 		$15.6M Hold
29,278
– – 0.03% 336
2015
Q4 		$20.5M Buy
29,278
+5,060
+21% +$3.33M 0.03% 309
2015
Q3 		$14.4M Buy
24,218
+9,153
+61% +$7.47M 0.02% 357
2015
Q2 		$12.5M Buy
+15,065
New +$13.1M 0.02% 404

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return